Sfoglia per AUTORE
TAMBURINI E
Collezione AO Ordine Mauriziano
Items : 6
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants. in Cancer medicine / Cancer Med. 2025 Feb;14(3):e70364. doi: 10.1002/cam4.70364.
2025
AO Ordine Mauriziano
AOU Novara
Bencardino K; Forti L; Spallanzani A; Paratore C; Bernardini I; Giommoni E; Mosconi S; Scartozzi M; Rodriquenz MG; Rapposelli IG; Niger M; Bittoni A; Palloni A; Carloni R; Bergamo F; Chiaravalli M; Gaule M; Cavaliere A; Macchini M; Giordano G; Vasile E; Garajova I; Bozzarelli S; Noventa S; Procaccio L; Salvatore L; di Marco M; Orsi G; Milella M; et alii...
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). in British journal of cancer / Br J Cancer. 2023 Mar;128(5):877-885. doi: 10.1038/s41416-022-02086-w. Epub 2022 Dec 8.
2023
AO Ordine Mauriziano
AOU Novara
Reni M; Cascinu S; Milella M; Forti L; Valente MM; Bernardino K; Tamburini E; Bernardini I; Niger M; Giommoni E; Peretti U; Spallanzani A; Paratore C; Procaccio L; Salvatore L; Bittoni A; Merelli B; Garajova I; De Lorenzo S; Rapposelli IG; Militello AM; Rodriquenz MG; Bozzarelli S; Noventa S; Scartozzi M; Vasile E; Di Marco M; Giordano G; Macchini M; et alii...
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM). in ESMO open / ESMO Open. 2022 Oct;7(5):100567. doi: 10.1016/j.esmoop.2022.100567. Epub 2022 Aug 19.
2022
AO Ordine Mauriziano
Ciardiello D; Chiarazzo C; Famiglietti V; Damato A; Pinto C; Zampino MG; Castellano G; Gervaso L; Zaniboni A; Oneda E; Rapisardi S; Bordonaro R; Zichi C; De Vita F; Di Maio M; Parisi A; Giampieri R; Berardi R; Lavacchi D; Antonuzzo L; Tamburini E; Maiorano BA; Parrella P; Latiano TP; Normanno N; De Stefano A; Avallone A; Martini G; Napolitano S; et alii...
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey. in ESMO open / ESMO Open. 2021 Oct;6(5):100238. doi: 10.1016/j.esmoop.2021.100238. Epub 2021 Aug 13.
2021
AO Ordine Mauriziano
AOU Novara
Reni M; Milella M; Cascinu S; Militello AM; Valente MM; Forti L; Scartozzi M; Giommoni E; Macchini M; Tamburini E; Bencardino K; Mosconi S; Spallanzani A; Paratore C; Bernardini I; Peretti U; Penzo E; De Lorenzo S; Rodriquenz MG; Bittoni A; Garajova I; Tortora G; Rapposelli IG; Giordano G; Noventa S; Bozzarelli S; Niger M; Cavaliere A; Di Marco M; et alii...
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. in Cancers / Cancers (Basel). 2021 Jun 7;13(11):2839. doi: 10.3390/cancers13112839.
2021
AO Ordine Mauriziano
Raimondi A; Palermo F; Prisciandaro M; Aglietta M; Antonuzzo L; Aprile G; Berardi R; Cardellino GG; De Manzoni G; De Vita F; Di Maio M; Fornaro L; Frassineti GL; Granetto C; Iachetta F; Lonardi S; Murialdo R; Ongaro E; Pucci F; Ratti M; Silvestris N; Smiroldo V; Spallanzani A; Strippoli A; Tamberi S; Tamburini E; Zaniboni A; Di Bartolomeo M; Cremolini C; et alii...
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Fontanini G; Di Maio M; Milione M; Volpi C; Fucà G; Sensi E; Tamburini E; Tampellini M; Baratelli C; Zucchelli G; Busico A; Gloghini A; Rossini D; Perrone F; Tamborini E; Berenato R; Morano F; Moretto R; Cremolini C; De Braud F; Falcone A; Pietrantonio F;